Business Description
Scholar Rock Holding Corp
NAICS : 325412
SIC : 2834
ISIN : US80706P1030
Description
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGF?1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.09 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.84 | |||||
| Debt-to-EBITDA | -0.29 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 10.1 | |||||
| 3-Year EPS without NRI Growth Rate | 10.9 | |||||
| 3-Year FCF Growth Rate | 5.9 | |||||
| 3-Year Book Growth Rate | -27.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.03 | |||||
| 9-Day RSI | 67.27 | |||||
| 14-Day RSI | 67.29 | |||||
| 6-1 Month Momentum % | 255.77 | |||||
| 12-1 Month Momentum % | 59.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.88 | |||||
| Quick Ratio | 3.88 | |||||
| Cash Ratio | 3.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -30.5 | |||||
| Shareholder Yield % | -2.12 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -143.29 | |||||
| ROA % | -91.48 | |||||
| ROIC % | -709.51 | |||||
| ROC (Joel Greenblatt) % | -1286.77 | |||||
| ROCE % | -108.26 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 46.07 | |||||
| Price-to-Tangible-Book | 46.02 | |||||
| EV-to-EBIT | -17.52 | |||||
| EV-to-EBITDA | -17.69 | |||||
| EV-to-Forward-Revenue | 1233.13 | |||||
| EV-to-FCF | -21.41 | |||||
| Price-to-Net-Current-Asset-Value | 69.03 | |||||
| Price-to-Net-Cash | 92.98 | |||||
| Earnings Yield (Greenblatt) % | -5.71 | |||||
| FCF Yield % | -4.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SRRK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Scholar Rock Holding Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.35 | ||
| Beta | 1.01 | ||
| Volatility % | 267.72 | ||
| 14-Day RSI | 67.29 | ||
| 14-Day ATR ($) | 2.67467 | ||
| 20-Day SMA ($) | 41.882 | ||
| 12-1 Month Momentum % | 59.57 | ||
| 52-Week Range ($) | 6.76 - 46.185 | ||
| Shares Outstanding (Mil) | 93.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Scholar Rock Holding Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Scholar Rock Holding Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Scholar Rock Holding Corp Frequently Asked Questions
What is Scholar Rock Holding Corp(SRRK)'s stock price today?
The current price of SRRK is $45.03. The 52 week high of SRRK is $46.19 and 52 week low is $6.76.
When is next earnings date of Scholar Rock Holding Corp(SRRK)?
The next earnings date of Scholar Rock Holding Corp(SRRK) is 2025-03-19 Est..
Does Scholar Rock Holding Corp(SRRK) pay dividends? If so, how much?
Scholar Rock Holding Corp(SRRK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers